Surface disinfectants used in healthcare environments.

IF 1.3 Q4 PHARMACOLOGY & PHARMACY
Isabel Romero Crespo, Maria Luisa Gaspar Carreño, Maria Cristina Muñoz Contreras
{"title":"Surface disinfectants used in healthcare environments.","authors":"Isabel Romero Crespo, Maria Luisa Gaspar Carreño, Maria Cristina Muñoz Contreras","doi":"10.1016/j.farma.2025.03.011","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Review the most relevant aspects to consider when selecting the optimal surface disinfectant for use in healthcare settings.</p><p><strong>Method: </strong>The review was conducted over a three-month period (January to March 2024) based on the list of healthcare surface disinfectants authorized by the Spanish Agency of Medicines and Medical Devices and those in a transitional period, with marketing allowed until their registration in the Official Biocide Register. Biocidal agents belonging to the categories of skin antiseptics and insect repellents were excluded. A total of 100 biocidal agents were selected and evenly distributed among four researchers. The review strategy involved consulting the marketing representatives of these products via email or by reviewing their technical datasheets on their respective websites. The reviewed aspects of each disinfectant included marketed presentations, declared efficacy, composition, indication, dosage, and usage instructions.</p><p><strong>Results: </strong>The total number of biocidal agents included in the study was 85. A total of 29 suppliers were consulted, covering 141 marketed presentations, 25 (29.41%) of which were sterile. Regarding the efficacy declared by suppliers, 100% (85 products) showed bactericidal activity, 81.18% (69) fungicidal activity, 78.82% (67) virucidal activity, 50.59% (43) yeasticidal activity, 20% (17) mycobactericidal/tuberculocidal activity, and 17.65% (15) sporicidal activity. In terms of usage instructions, 40 of the 85 biocides (47.06%) were presented in a ready-to-use dosage format, and 34 (40%) allowed for cleaning and disinfection in a single step. A total of 14 biocides (16.47%) included airborne disinfection options.</p><p><strong>Conclusions: </strong>Selecting the most appropriate surface disinfectant is not straightforward, given the wide range of marketed products, the number of factors to consider, and the fact that not all products meet every criterion. For this reason, the selection process must be accompanied by the implementation of optimized programs aimed at reducing the transmission of pathogens from surfaces to patients and healthcare personnel.</p>","PeriodicalId":45860,"journal":{"name":"FARMACIA HOSPITALARIA","volume":" ","pages":""},"PeriodicalIF":1.3000,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FARMACIA HOSPITALARIA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.farma.2025.03.011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Review the most relevant aspects to consider when selecting the optimal surface disinfectant for use in healthcare settings.

Method: The review was conducted over a three-month period (January to March 2024) based on the list of healthcare surface disinfectants authorized by the Spanish Agency of Medicines and Medical Devices and those in a transitional period, with marketing allowed until their registration in the Official Biocide Register. Biocidal agents belonging to the categories of skin antiseptics and insect repellents were excluded. A total of 100 biocidal agents were selected and evenly distributed among four researchers. The review strategy involved consulting the marketing representatives of these products via email or by reviewing their technical datasheets on their respective websites. The reviewed aspects of each disinfectant included marketed presentations, declared efficacy, composition, indication, dosage, and usage instructions.

Results: The total number of biocidal agents included in the study was 85. A total of 29 suppliers were consulted, covering 141 marketed presentations, 25 (29.41%) of which were sterile. Regarding the efficacy declared by suppliers, 100% (85 products) showed bactericidal activity, 81.18% (69) fungicidal activity, 78.82% (67) virucidal activity, 50.59% (43) yeasticidal activity, 20% (17) mycobactericidal/tuberculocidal activity, and 17.65% (15) sporicidal activity. In terms of usage instructions, 40 of the 85 biocides (47.06%) were presented in a ready-to-use dosage format, and 34 (40%) allowed for cleaning and disinfection in a single step. A total of 14 biocides (16.47%) included airborne disinfection options.

Conclusions: Selecting the most appropriate surface disinfectant is not straightforward, given the wide range of marketed products, the number of factors to consider, and the fact that not all products meet every criterion. For this reason, the selection process must be accompanied by the implementation of optimized programs aimed at reducing the transmission of pathogens from surfaces to patients and healthcare personnel.

医疗环境中使用的表面消毒剂。
目的:回顾在卫生保健环境中选择最佳表面消毒剂时应考虑的最相关方面。方法:根据西班牙药品和医疗器械管理局批准的卫生保健表面消毒剂清单以及在官方杀菌剂登记册上注册之前允许上市的过渡期清单,进行为期三个月(2024年1月至3月)的审查。不包括皮肤防腐剂和驱虫剂类的杀菌剂。共选择了100种杀菌剂,平均分配给4名研究人员。审查策略包括通过电子邮件咨询这些产品的营销代表,或者在他们各自的网站上审查他们的技术数据表。每种消毒剂的审查方面包括上市介绍、宣布的功效、成分、适应症、剂量和使用说明。结果:本研究共纳入85种杀菌剂。共咨询29家供应商,共141种上市产品,其中25种(29.41%)无菌。在供方申报的功效中,100%(85种)产品的杀菌活性、81.18%(69种)的杀真菌活性、78.82%(67种)的杀病毒活性、50.59%(43种)的杀酵母活性、20%(17种)的杀分枝杆菌/结核菌活性、17.65%(15种)的杀孢子活性。在使用说明方面,85种杀菌剂中有40种(47.06%)以即用剂量形式呈现,34种(40%)允许一次清洗和消毒。含空气消毒选项的杀菌剂共有14种(16.47%)。结论:考虑到市场上销售的产品种类繁多,需要考虑的因素众多,而且并非所有产品都符合每一项标准,选择最合适的表面消毒剂并非易事。出于这个原因,选择过程必须伴随着旨在减少病原体从表面传播到患者和医护人员的优化方案的实施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
FARMACIA HOSPITALARIA
FARMACIA HOSPITALARIA PHARMACOLOGY & PHARMACY-
CiteScore
1.90
自引率
21.40%
发文量
46
审稿时长
37 days
期刊介绍: Una gran revista para acceder a los mejores artículos originales y revisiones de la farmacoterapia actual. Además, es Órgano de expresión científica de la Sociedad Española de Farmacia Hospitalaria, y está indexada en Index Medicus/Medline, EMBASE/Excerpta Médica, Alert, Internacional Pharmaceutical Abstracts y SCOPUS.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信